Skip to the page

Data / Form D filings / RareCyte, Inc.

RareCyte, Inc.: Form D filings

RareCyte, Inc., a company in Seattle, WA, filed 5 Form D notices with the SEC between 2017 and 2023. The latest, on July 25, 2023, reports $13.2 million sold of a $35.7 million offering to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2601 4th Avenue, #500, Seattle, WA, 98121
Phone
(855) 727-3298
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1653064

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 25, 2023New notice$35,689,152$13,174,795$22,514,35719Jul 12, 2023sec.gov
Sep 10, 2021New notice$24,046,147$24,046,14727Aug 19, 2021sec.gov
Dec 26, 2019New notice$22,156,736$22,156,7360Dec 11, 2019sec.gov
May 24, 2018New notice$4,999,999$4,999,9991May 10, 2018sec.gov
Aug 10, 2017New notice$16,348,900$15,399,995$948,9059Jul 27, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David J. KabakoffDirector
Ronald J. SeubertDirector
Robert J. WeisskoffDirector
Daniel J. MarshakDirector
Jan J. GarfinkleDirector
Andrew J. SchwabDirector
Stephen J. ReichenbachExecutive Officer
Joseph J. Victor Jr.Executive Officer, Director

Other companies in Washington that filed recently

Every Form D from the week of Jul 24, 2023 · All recent filings in Washington · All recent Other filings

Read from SEC EDGAR. Amount sold is what RareCyte, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.